Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3�� and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis.

Jing Yang, Fahim Syed, Ying Xia, Arun J Sanyal, Vijay H Shah, Naga Chalasani, Xiaoqun Zheng, Qigui Yu, Yongliang Lou, Wei Li
Author Information
  1. Jing Yang: School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  2. Fahim Syed: Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  3. Ying Xia: School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  4. Arun J Sanyal: Division of Gastroenterology and Hepatology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  5. Vijay H Shah: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  6. Naga Chalasani: Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  7. Xiaoqun Zheng: Department of Clinical Laboratory, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  8. Qigui Yu: Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  9. Yongliang Lou: School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  10. Wei Li: Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA. ORCID

Abstract

BACKGROUND: Heavy alcohol consumption disrupts gut epithelial integrity, leading to increased permeability of the gastrointestinal tract and subsequent translocation of microbes. Regenerating islet-derived protein 3�� (REG3��) and Trefoil factor 3 (TFF3) are mainly secreted to the gut lumen by Paneth and Goblet cells, respectively, and are functionally linked to gut barrier integrity. Circulating levels of REG3�� and TFF3 have been identified as biomarkers for gut damage in several human diseases. We examined whether plasma levels of REG3�� and TFF3 were dysregulated and correlated with conventional markers of microbial translocation (MT) and pro-inflammatory mediators in heavy drinkers with and without alcoholic hepatitis (AH).
METHODS: Cross-sectional and longitudinal studies were performed to monitor plasma levels of REG3�� and TFF3 in 79 AH patients, 66 heavy drinkers without liver disease (HDC), and 46 healthy controls (HC) at enrollment and at 6- and 12-month follow-ups. Spearman correlation was used to measure the relationships of REG3�� and TFF3 levels with MT, disease severity, inflammation, and effects of abstinence from alcohol.
RESULTS: At enrollment, AH patients had significantly higher levels of REG3�� and TFF3 than HDC and HC. The elevated REG3�� levels were positively correlated with the 30-day fatality rate. Plasma levels of REG3�� and TFF3 in AH patients differentially correlated with conventional MT markers (sCD14, sCD163, and LBP) and several highly up-regulated inflammatory cytokines/chemokines/growth factors. At follow-ups, although REG3�� and TFF3 levels were decreased in AH patients with alcohol abstinence, they did not fully return to baseline levels.
CONCLUSIONS: Circulating levels of REG3�� and TFF3 were highly elevated in AH patients and differentially correlated with AH disease severity, MT, and inflammation, thereby serving as potential biomarkers of MT and gut epithelial damage in AH patients.

Keywords

References

  1. Sci Rep. 2017 Jun 30;7(1):4462 [PMID: 28667254]
  2. Front Immunol. 2018 Nov 30;9:2795 [PMID: 30555477]
  3. Clin Chem. 2002 Oct;48(10):1689-95 [PMID: 12324485]
  4. Alcohol Alcohol. 2017 Jul 1;52(4):414-424 [PMID: 28482064]
  5. Alcohol Clin Exp Res. 2011 May;35(5):787-93 [PMID: 21284667]
  6. Gut. 2005 Sep;54(9):1244-53 [PMID: 15870231]
  7. Cells. 2020 Aug 17;9(8): [PMID: 32824536]
  8. Immunol Rev. 2009 Jan;227(1):106-28 [PMID: 19120480]
  9. Gastroenterology. 2011 Nov;141(5):1572-85 [PMID: 21920463]
  10. Alcohol Res. 2015;37(2):159-70 [PMID: 26695755]
  11. Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):641-656 [PMID: 29806487]
  12. Endocrinology. 2019 Jun 1;160(6):1506-1514 [PMID: 31070724]
  13. Nat Med. 2008 Mar;14(3):282-9 [PMID: 18264109]
  14. J Neurochem. 2012 Jun;121(5):785-92 [PMID: 22380637]
  15. Front Cell Dev Biol. 2019 Oct 22;7:235 [PMID: 31696115]
  16. J Clin Invest. 2018 Nov 1;128(11):4970-4979 [PMID: 30106382]
  17. Clin Transl Gastroenterol. 2019 Jun;10(6):e00052 [PMID: 31211759]
  18. Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G516-25 [PMID: 21252049]
  19. Aliment Pharmacol Ther. 2014 Oct;40(8):974-81 [PMID: 25112824]
  20. Alcohol Res. 2015;37(2):223-36 [PMID: 26695747]
  21. Trends Microbiol. 2004 Aug;12(8):394-8 [PMID: 15276616]
  22. Hepatology. 2010 Oct;52(4):1291-300 [PMID: 20842630]
  23. J Hepatol. 2018 Oct;69(4):886-895 [PMID: 29803899]
  24. PLoS Pathog. 2017 Jun 12;13(6):e1006426 [PMID: 28604843]
  25. Hepatology. 2018 Apr;67(4):1284-1302 [PMID: 29083504]
  26. Annu Rev Immunol. 2015;33:747-85 [PMID: 25706098]
  27. Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):166S-71S [PMID: 16344604]
  28. Blood. 2011 Dec 15;118(25):6702-8 [PMID: 21979939]
  29. Alcohol Clin Exp Res. 2018 Jan;42(1):32-40 [PMID: 29030980]
  30. J Gastroenterol. 2019 Mar;54(3):209-217 [PMID: 30392013]
  31. World J Hepatol. 2012 Mar 27;4(3):81-90 [PMID: 22489260]
  32. Cell Host Microbe. 2016 Feb 10;19(2):227-39 [PMID: 26867181]
  33. J Crohns Colitis. 2015 Jul;9(7):575-9 [PMID: 25964429]
  34. Alcohol. 2015 Feb;49(1):65-70 [PMID: 25559494]
  35. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1831-1838.e3 [PMID: 27320325]
  36. Am J Physiol Cell Physiol. 2017 Sep 1;313(3):C305-C313 [PMID: 28637673]
  37. Annu Rev Physiol. 2017 Feb 10;79:357-380 [PMID: 27992733]
  38. Hepatol Commun. 2020 Jan 12;4(4):588-605 [PMID: 32258953]
  39. BMC Gastroenterol. 2014 Apr 11;14:74 [PMID: 24720760]
  40. J Pharmacol Exp Ther. 2003 Jun;305(3):880-6 [PMID: 12626662]
  41. Hepatology. 2010 Jan;51(1):307-28 [PMID: 20034030]
  42. Annu Rev Physiol. 2009;71:241-60 [PMID: 18808327]
  43. Alcohol Res. 2015;37(2):185-97 [PMID: 26695744]
  44. Am J Physiol Gastrointest Liver Physiol. 2014 Apr 15;306(8):G677-85 [PMID: 24557761]
  45. Alcohol Clin Exp Res. 2015 May;39(5):763-75 [PMID: 25872593]
  46. Hepatology. 2011 Jan;53(1):96-105 [PMID: 21254165]
  47. Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G966-78 [PMID: 22241860]
  48. FEBS Lett. 1998 Nov 13;439(1-2):180-4 [PMID: 9849902]
  49. World J Gastrointest Surg. 2010 Mar 27;2(3):61-9 [PMID: 21160852]
  50. Prog Clin Biol Res. 1998;397:79-87 [PMID: 9575549]
  51. Peptides. 2004 May;25(5):849-54 [PMID: 15177881]
  52. Alcohol Clin Exp Res. 2014 Aug;38(8):2217-24 [PMID: 25156614]
  53. Nat Commun. 2016 Nov 10;7:13393 [PMID: 27830702]
  54. Gut Microbes. 2019;10(6):663-675 [PMID: 30894059]
  55. Hepatology. 2017 Aug;66(2):575-590 [PMID: 28466561]
  56. J Clin Gastroenterol. 2011 Sep;45(8):714-9 [PMID: 21085006]
  57. Curr Diabetes Rev. 2014 May;10(3):190-200 [PMID: 24828062]
  58. Exp Ther Med. 2011 Jul;2(4):705-713 [PMID: 22977563]
  59. Gut. 2018 May;67(5):918-930 [PMID: 29097439]
  60. Hepatol Commun. 2018 Feb 28;2(4):393-406 [PMID: 29619418]
  61. Mucosal Immunol. 2008 Sep;1(5):335-8 [PMID: 19079197]
  62. Shock. 2013 Jan;39(1):11-8 [PMID: 23143063]
  63. AIDS. 2015 Jun 19;29(10):1263-5 [PMID: 26035325]
  64. Alcohol Res Health. 2003;27(4):300-6 [PMID: 15540801]
  65. Alcohol Clin Exp Res. 2020 May;44(5):1075-1087 [PMID: 32246771]
  66. Mediators Inflamm. 2015;2015:738563 [PMID: 26346822]
  67. Hepatology. 2019 Oct;70(4):1134-1149 [PMID: 30891779]

Grants

  1. U01 AA021883/NIAAA NIH HHS
  2. U01 AA021840/NIAAA NIH HHS
  3. UH2 AA026218/NIAAA NIH HHS
  4. U01 AA026979/NIAAA NIH HHS
  5. UH3 AA026218/NIAAA NIH HHS
  6. U01 AA021891/NIAAA NIH HHS
  7. U01 AA021788/NIAAA NIH HHS
  8. U01 AA026974/NIAAA NIH HHS

MeSH Term

Adult
Alcohol Abstinence
Bacterial Translocation
Biomarkers
Case-Control Studies
Female
Hepatitis, Alcoholic
Humans
Inflammation
Interleukins
Intestinal Mucosa
Male
Middle Aged
Pancreatitis-Associated Proteins
Severity of Illness Index
Trefoil Factor-3
Interleukin-22

Chemicals

Biomarkers
Interleukins
Pancreatitis-Associated Proteins
REG3A protein, human
TFF3 protein, human
Trefoil Factor-3

Word Cloud

Created with Highcharts 10.0.0REG3��TFF3levelsAHpatientsgutMTcorrelatedalcoholdiseaseepithelialintegritytranslocationRegenerating3��Trefoil3CirculatingbiomarkersdamageseveralplasmaconventionalmarkersheavydrinkerswithoutHDCHCenrollmentfollow-upsseverityinflammationabstinenceelevateddifferentiallyhighlyDamageAlcoholicHepatitisBACKGROUND:Heavyconsumptiondisruptsleadingincreasedpermeabilitygastrointestinaltractsubsequentmicrobesislet-derivedproteinfactormainlysecretedlumenPanethGobletcellsrespectivelyfunctionallylinkedbarrieridentifiedhumandiseasesexaminedwhetherdysregulatedmicrobialpro-inflammatorymediatorsalcoholichepatitisMETHODS:Cross-sectionallongitudinalstudiesperformedmonitor7966liver46healthycontrols6-12-monthSpearmancorrelationusedmeasurerelationshipseffectsRESULTS:significantlyhigherpositively30-dayfatalityratePlasmasCD14sCD163LBPup-regulatedinflammatorycytokines/chemokines/growthfactorsalthoughdecreasedfullyreturnbaselineCONCLUSIONS:therebyservingpotentialBloodBiomarkersIntestinalEpitheliumIslet-derivedProteinFactorPersistentlyElevatedPatientsGutEpithelialImmuneActivationInflammationMicrobialTranslocation

Similar Articles

Cited By